Statistics for Ocuphire Pharma, (id:5605 OCUP)

Valuation metrics

Market cap

31.74M

Enterprise value

-11,809,758.00

Trailing P/E (ttm)

1.38

Forward P/E

-1.30

PEG ratio

-1.30

Price/Sales (ttm)

1.93

Price/Book (mrq)

0.75

Enterprise Value/Revenue

-0.72

Enterprise Value/EBITDA

0.78

Overview

Shares outstanding

26.20M

Float

24.52M

Shares short

930.64K

% Held by insiders

0.06%

% Held by institutions

0.09%

Average volume (10 days)

229.74K

Average volume (90 days)

Price summary

52-Week low

0.85

52-Week high

3.40

52-Week change

-187.57%

Beta

0.31

50-Day moving average

1.27

200-Day moving average

1.74

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

November 06th, 2020

Ex-dividend date

Last split factor

2:1

Last split date

November 06th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-85.75%

Operating margin

-748.92%

Operational effectiveness

Return on assets

-21.35%

Return on equity

-36.01%

Income statement

Revenue (ttm)

0.69

Revenue per share (ttm)

0.69

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-15,072,000.00

Net income to common (ttm)

-14,105,000.00

Diluted EPS (ttm)

-0.54

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

41.41M

Total cash per share (mrq)

1.58

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

1.07K%

Book value per share (mrq)

1.56

Cash flow

Cash flow statement

-11,463,000.00

Levered free cash flow (LFCF)

-8,696,375.00